With a truly patient-focussed approach we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Sourcing commercial drug products for clinical trials can be a complex process and is often one of the last considerations during study design. Our experienced Global Sourcing Team is uniquely positioned to support you through the commercial drug sourcing process with their deep understanding of clinical trials and commercial drug markets.
Download here
Bionical Emas Earns ‘B’ Rating from the Carbon Disclosure Project, and Reinforces Commitment to Sustainability
Bionical Emas has been awarded a ‘B’ rating by the Carbon Disclosure Project (CDP), recognizing its progress in environmental transparency and sustainability efforts. This achievement reflects the company’s dedication to reducing its carbon footprint and integrating sustainable practices across its operations.
In response to the rating, Bionical Emas has reaffirmed its commitment to strengthening its climate initiatives, with plans to enhance its corporate sustainability strategy. The company continues to engage with stakeholders, ensuring its environmental impact aligns with global sustainability goals.
“We are proud of this recognition from the CDP, and it reinforces our ongoing drive to implement greener solutions. While we celebrate this milestone, we recognize there is more to do and remain committed to continuous improvement in our sustainability journey.” Tom Watson, CEO, Bionical Emas
As part of its long-term strategy, Bionical Emas aims to enhance carbon reduction measures and support global efforts to combat climate change, working towards a more sustainable future for businesses and communities alike.
Bionical Emas is a global Early Access Programs (EAP) and Clinical Trial Supply (CTS) organization bringing life-changing medicines to patients around the world. Their comprehensive suite of services and capabilities benefit many of the world’s leading pharma and biotech companies.
The Carbon Disclosure Project promotes annual environmental reporting and transparency as critical for building a sustainable economy, combating climate change, and creating a net-zero future. CDP claims the most comprehensive collection of self-reported environmental data in the world.
For further information, please contact:
Becky Coates
Organisational Development Manager, Bionical Emas
Becky.Coates@BionicalEmas.com
